Damon Runyon Researchers

Meet Our Scientists
Sean C. Bendall, PhD

Dr. Bendall is using novel single-cell analysis techniques to investigate how normal regulatory cell signaling networks are rewired, allowing cancer to grow unchecked.  He has applied this technology to examine healthy human blood cells, measuring multiple parameters simultaneously in single cells.  Collectively, such single-cell analyses provide an unprecedented opportunity to identify novel regulators (such as drugs, genes, and protein modifications) of cell development and identity, as well as provide insight into how these regulators interact with genes and mutations that promote cancer cell transformation.  His goal is to use these studies to contribute to the development of more effective diagnostics and treatments to improve clinical outcomes. 

Project title: "Improved single-cell phosphoprotein signaling analysis of oncogenic progression in leukemia"
Institution: Stanford University
Award Program: Dale Frey Scientist
Cancer Type: Blood, All Cancers
Research Area: Proteomics